We are live on ! Find out more
Aster Capital Management

Aster Capital Management Portfolio holdings

AUM $275M Turnover 72.56%
1-Year Est. Return 18.46%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+18.46%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$275M
AUM Growth
-$195M
Cap. Flow
-$180M
Cap. Flow %
-65.37%
Top 10 Hldgs %
10.94%
Holding
1,392
New
584
Increased
169
Reduced
213
Closed
426
Avg Time Held
0.2 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.57M
2
OVV icon
Ovintiv
OVV
+$3.99M
3
KIM icon
Kimco Realty
KIM
+$3.52M
4
ALAB icon
Astera Labs
ALAB
+$3.33M
5
HUT icon
Hut 8
HUT
+$2.16M

Top Sells

Rank Stock Value
1
IYR icon
iShares US Real Estate ETF
IYR
+$11.3M
2
AAPL icon
Apple
AAPL
+$7.75M
3
MSFT icon
Microsoft
MSFT
+$6.82M
4
HON icon
Honeywell
HON
+$6.34M
5
KO icon
Coca-Cola
KO
+$5.38M

Sector Composition

Rank Sector Weight
1 Financials 16.08%
2 Technology 15.72%
3 Industrials 13.9%
4 Healthcare 13.43%
5 Consumer Discretionary 10.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ETON icon
726
Eton Pharmaceutcials
ETON
$1.77B
$15.8K 0.01%
306
+271
+774% +$13.8K
2026 Q2
1 quarter
SGP icon
727
SpyGlass Pharma
SGP
$1.03B
$15.5K 0.01%
+598
New +$14.7K
2026 Q3
0 quarters
MCHB icon
728
Mechanics Bancorp
MCHB
$3.08B
$15.5K 0.01%
1,048
+713
+213% +$11.4K
2026 Q2
1 quarter
WVE icon
729
Wave Life Sciences
WVE
$536M
$15.4K 0.01%
+4,169
New +$21.9K
2026 Q3
0 quarters
ATMU icon
730
Atmus Filtration Technologies
ATMU
$4.32B
$15.3K 0.01%
+353
New +$17.3K
2026 Q3
0 quarters
CRK icon
731
Comstock Resources
CRK
$3.81B
$15.2K 0.01%
1,235
+254
+26% +$3.5K
2026 Q2
1 quarter
FSUN icon
732
FirstSun Capital Bancorp
FSUN
$1.64B
$15K 0.01%
+388
New +$15.1K
2026 Q3
0 quarters
ANRO icon
733
Alto Neuroscience
ANRO
$1.06B
$14.9K 0.01%
582
+447
+331% +$13.4K
2026 Q2
1 quarter
DEI icon
734
Douglas Emmett
DEI
$1.58B
$14.7K 0.01%
1,530
-1,035
-40% -$11.9K
2025 Q3
4 quarters
AKTS icon
735
Aktis Oncology
AKTS
$915M
$14.6K 0.01%
+748
New +$18.2K
2026 Q3
0 quarters
LQDT icon
736
Liquidity Services
LQDT
$1.03B
$14.3K 0.01%
+334
New +$13.7K
2026 Q3
0 quarters
DCO icon
737
Ducommun
DCO
$2.11B
$14.2K 0.01%
+83
New +$14.8K
2026 Q3
0 quarters
NUTX icon
738
Nutex Health
NUTX
$1.11B
$14K 0.01%
66
+49
+288% +$9.01K
2026 Q2
1 quarter
HTLD icon
739
Heartland Express
HTLD
$780M
$13.7K 0.01%
+1,181
New +$15.3K
2026 Q3
0 quarters
VOR icon
740
Vor Biopharma
VOR
$1.14B
$13.6K ﹤0.01%
+712
New +$15.2K
2026 Q3
0 quarters
GS icon
741
Goldman Sachs
GS
$244B
$13.5K ﹤0.01%
+15
New +$15.3K
2026 Q3
0 quarters
C icon
742
Citigroup
C
$191B
$13.5K ﹤0.01%
+104
New +$14K
2026 Q3
0 quarters
TARS icon
743
Tarsus Pharmaceuticals
TARS
$3.83B
$13.4K ﹤0.01%
170
+50
+42% +$3.47K
2026 Q2
1 quarter
CNK icon
744
Cinemark Holdings
CNK
$4.55B
$13.2K ﹤0.01%
+354
New +$12.3K
2026 Q3
0 quarters
BRC icon
745
Brady
BRC
$3.45B
$13.2K ﹤0.01%
+158
New +$14.4K
2026 Q3
0 quarters
BFH icon
746
Bread Financial
BFH
$3.55B
$13K ﹤0.01%
+133
New +$14K
2026 Q3
0 quarters
ING icon
747
ING
ING
$86.9B
$13K ﹤0.01%
+365
New +$12.7K
2026 Q3
0 quarters
CRCT icon
748
Cricut
CRCT
$1.73B
$12.9K ﹤0.01%
2,015
+951
+89% +$5.06K
2026 Q2
1 quarter
WHD icon
749
Cactus
WHD
$4.84B
$12.8K ﹤0.01%
+206
New +$13.1K
2026 Q3
0 quarters
KTB icon
750
Kontoor Brands
KTB
$4.34B
$12.5K ﹤0.01%
+199
New +$15.5K
2026 Q3
0 quarters

Similar funds

Aster Capital Management's Q3 2026 Portfolio in Review

As of Q3 2026, Aster Capital Management held 1,392 positions worth $275M, down 41% from $470M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Aster Capital Management withdrew a net $180M in Q3 2026, closing 426 positions and reducing 213 holdings. Its most notable exit was iShares US Real Estate ETF, an estimated $11.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Aster Capital Management opened a new position in Alnylam Pharmaceuticals worth $4.43M.

  • Aster Capital Management's largest Q3 2026 buy was Alnylam Pharmaceuticals: 17,949 shares worth $4.43M.
  • Aster Capital Management added most to Simon Property Group in Q3 2026, an estimated $1.93M increase.
  • Aster Capital Management's biggest Q3 2026 reduction was Meta Platforms (Facebook), cutting an estimated $4.29M.
  • Aster Capital Management fully exited iShares US Real Estate ETF in Q3 2026, selling an estimated $11.3M.
  • Aster Capital Management's ten largest holdings make up 11% of its $275M portfolio in Q3 2026.
  • Aster Capital Management opened 584 new positions and closed 426 in Q3 2026.
  • Aster Capital Management's portfolio value fell 41% quarter-over-quarter to $275M.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.